{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:48Z","timestamp":1772119728782,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09707-y","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T05:02:11Z","timestamp":1723093331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["XRCC1 and XPD polymorphisms: clinical outcomes and risk of prostate cancer in Bangladeshi population"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5584-0910","authenticated-orcid":false,"given":"Nafisa","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-4891","authenticated-orcid":false,"given":"Md. Ariful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8307-0028","authenticated-orcid":false,"given":"M. Mahboob","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0242-9199","authenticated-orcid":false,"given":"Yearul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"issue":"3","key":"9707_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"9707_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/s1470-2045(23)00148-1","volume":"24","author":"G Attard","year":"2023","unstructured":"Attard G, Murphy L, Clarke NW, Sachdeva A, Jones C, Hoyle A et al (2023) Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol. Lancet Oncol 24(5):443\u2013456. https:\/\/doi.org\/10.1016\/s1470-2045(23)00148-1","journal-title":"Lancet Oncol"},{"issue":"1","key":"9707_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5334\/aogh.2607","volume":"86","author":"S Hassanipour","year":"2020","unstructured":"Hassanipour S, Delam H, Arab-Zozani M, Abdzadeh E, Hosseini SA, Nikbakht HA et al (2020) Survival rate of prostate Cancer in Asian countries: a systematic review and Meta-analysis. Ann Glob Health 86(1):2. https:\/\/doi.org\/10.5334\/aogh.2607","journal-title":"Ann Glob Health"},{"issue":"6","key":"9707_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","volume":"61","author":"MM Center","year":"2012","unstructured":"Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61(6):1079\u20131092. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.054","journal-title":"Eur Urol"},{"issue":"2","key":"9707_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13167-019-00169-y","volume":"10","author":"R Sharma","year":"2019","unstructured":"Sharma R (2019) The burden of prostate cancer is associated with human development index: evidence from 87 countries, 1990\u20132016. Epma j 10(2):137\u2013152. https:\/\/doi.org\/10.1007\/s13167-019-00169-y","journal-title":"Epma j"},{"issue":"3","key":"9707_CR6","doi-asserted-by":"publisher","first-page":"101042831983083","DOI":"10.1177\/1010428319830837","volume":"41","author":"H Imtiaz","year":"2019","unstructured":"Imtiaz H, Afroz S, Hossain MA, Bellah SF, Rahman MM, Kadir MS et al (2019) Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population. Tumour Biol 41(3):1010428319830837. https:\/\/doi.org\/10.1177\/1010428319830837","journal-title":"Tumour Biol"},{"issue":"23","key":"9707_CR7","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I et al (2019) Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci U S A 116(23):11428\u201311436. https:\/\/doi.org\/10.1073\/pnas.1902651116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9707_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.juro.2018.10.015","volume":"201","author":"S Li-Sheng Chen","year":"2019","unstructured":"Li-Sheng Chen S, Ching-Yuan Fann J, Sipeky C, Yang TK, Yueh-Hsia Chiu S, Ming-Fang Yen A et al (2019) Risk prediction of prostate Cancer with single nucleotide polymorphisms and prostate specific Antigen. J Urol 201(3):486\u2013495. https:\/\/doi.org\/10.1016\/j.juro.2018.10.015","journal-title":"J Urol"},{"issue":"5","key":"9707_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.eururo.2019.03.020","volume":"76","author":"WS Chen","year":"2019","unstructured":"Chen WS, Aggarwal R, Zhang L, Zhao SG, Thomas GV, Beer TM et al (2019) Genomic drivers of poor prognosis and Enzalutamide Resistance in Metastatic Castration-resistant prostate Cancer. Eur Urol 76(5):562\u2013571. https:\/\/doi.org\/10.1016\/j.eururo.2019.03.020","journal-title":"Eur Urol"},{"issue":"5","key":"9707_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/14728222.2021.1951226","volume":"25","author":"S Boussios","year":"2021","unstructured":"Boussios S, Rassy E, Shah S, Ioannidou E, Sheriff M, Pavlidis N (2021) Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology. Expert Opin Ther Targets 25(5):329\u2013333. https:\/\/doi.org\/10.1080\/14728222.2021.1951226","journal-title":"Expert Opin Ther Targets"},{"issue":"24","key":"9707_CR11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.21037\/atm-20-2920","volume":"8","author":"M Jiang","year":"2020","unstructured":"Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y et al (2020) Alterations of DNA damage repair in cancer: from mechanisms to applications. Ann Transl Med 8(24):1685. https:\/\/doi.org\/10.21037\/atm-20-2920","journal-title":"Ann Transl Med"},{"issue":"5","key":"9707_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.semcancer.2010.10.010","volume":"20","author":"AA Nemec","year":"2010","unstructured":"Nemec AA, Wallace SS, Sweasy JB (2010) Variant base excision repair proteins: contributors to genomic instability. Semin Cancer Biol 20(5):320\u2013328. https:\/\/doi.org\/10.1016\/j.semcancer.2010.10.010","journal-title":"Semin Cancer Biol"},{"key":"9707_CR13","doi-asserted-by":"publisher","first-page":"102664","DOI":"10.1016\/j.dnarep.2019.102664","volume":"81","author":"KW Caldecott","year":"2019","unstructured":"Caldecott KW (2019) XRCC1 protein; form and function. DNA Repair (Amst) 81:102664. https:\/\/doi.org\/10.1016\/j.dnarep.2019.102664","journal-title":"DNA Repair (Amst)"},{"issue":"1\u20132","key":"9707_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000132829","volume":"52","author":"HW Mohrenweiser","year":"1989","unstructured":"Mohrenweiser HW, Carrano AV, Fertitta A, Perry B, Thompson LH, Tucker JD et al (1989) Refined mapping of the three DNA repair genes, ERCC1, ERCC2, and XRCC1, on human chromosome 19. Cytogenet Cell Genet 52(1\u20132):11\u201314. https:\/\/doi.org\/10.1159\/000132829","journal-title":"Cytogenet Cell Genet"},{"issue":"6","key":"9707_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.15537\/Smj.2016.6.13540","volume":"37","author":"C Jalali","year":"2016","unstructured":"Jalali C, Ghaderi B, Amini S, Abdi M, Roshani D (2016) Association of XRCC1 Trp194 allele with risk of breast cancer, and Ki67 protein status in breast tumor tissues. Saudi Med J 37(6):624\u2013630. https:\/\/doi.org\/10.15537\/Smj.2016.6.13540","journal-title":"Saudi Med J"},{"issue":"8","key":"9707_CR16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/carcin\/23.8.1321","volume":"23","author":"S Chen","year":"2002","unstructured":"Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y et al (2002) DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23(8):1321\u20131325. https:\/\/doi.org\/10.1093\/carcin\/23.8.1321","journal-title":"Carcinogenesis"},{"issue":"3","key":"9707_CR17","first-page":"3160","volume":"8","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang K, Liu X, Liu B, Wang Z (2015) Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer. Int J Clin Exp Pathol 8(3):3160\u20133167","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"9707_CR18","first-page":"125","volume":"10","author":"MC Stern","year":"2001","unstructured":"Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA (2001) DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 10(2):125\u2013131","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"9707_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.12669\/pjms.312.6653","volume":"31","author":"H Zhu","year":"2015","unstructured":"Zhu H, Jiu T, Wang D (2015) Impact of polymorphisms of the DNA repair gene XRCC1 and their role in the risk of prostate cancer. Pak J Med Sci 31(2):290\u2013294. https:\/\/doi.org\/10.12669\/pjms.312.6653","journal-title":"Pak J Med Sci"},{"issue":"1","key":"9707_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1743-7563.2008.00140.x","volume":"4","author":"T HAMANO","year":"2008","unstructured":"HAMANO T, MATSUI H, OHTAKE N (2008) Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population. Asia-Pac J Clin Oncol 4(1):21\u201326. https:\/\/doi.org\/10.1111\/j.1743-7563.2008.00140.x","journal-title":"Asia-Pac J Clin Oncol"},{"issue":"3","key":"9707_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.radonc.2011.01.021","volume":"98","author":"T Langsenlehner","year":"2011","unstructured":"Langsenlehner T, Renner W, Gerger A, Hofmann G, Thurner EM, Kapp KS et al (2011) Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother Oncol 98(3):387\u2013393. https:\/\/doi.org\/10.1016\/j.radonc.2011.01.021","journal-title":"Radiother Oncol"},{"issue":"22 Pt 1","key":"9707_CR22","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1158\/1078-0432.Ccr-07-1437","volume":"13","author":"SP Huang","year":"2007","unstructured":"Huang SP, Huang CY, Wang JS, Liu CC, Pu YS, Yu HJ et al (2007) Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy. Clin Cancer Res 13(22 Pt 1):6632\u20136638. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-1437","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9707_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.32607\/20758251-2014-6-1-23-34","volume":"6","author":"IO Petruseva","year":"2014","unstructured":"Petruseva IO, Evdokimov AN, Lavrik OI (2014) Molecular mechanism of global genome nucleotide excision repair. Acta Naturae 6(1):23\u201334","journal-title":"Acta Naturae"},{"key":"9707_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fmolb.2018.00023","volume":"5","author":"AS Sameer","year":"2018","unstructured":"Sameer AS, Nissar S (2018) XPD-The Lynchpin of NER: molecule, Gene, polymorphisms, and role in colorectal carcinogenesis. Front Mol Biosci 5:23. https:\/\/doi.org\/10.3389\/fmolb.2018.00023","journal-title":"Front Mol Biosci"},{"key":"9707_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-0-387-09599-8_5","volume":"637","author":"BD Beck","year":"2008","unstructured":"Beck BD, Hah DS, Lee SH (2008) XPB and XPD between transcription and DNA repair. Adv Exp Med Biol 637:39\u201346. https:\/\/doi.org\/10.1007\/978-0-387-09599-8_5","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"9707_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/crj.12218","volume":"10","author":"Y Du","year":"2016","unstructured":"Du Y, He Y, Mei Z, Qian L, Shi J, Jie Z (2016) Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population. Clin Respir J 10(3):311\u2013317. https:\/\/doi.org\/10.1111\/crj.12218","journal-title":"Clin Respir J"},{"issue":"1","key":"9707_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3892\/ol.2010.220","volume":"2","author":"M Samson","year":"2011","unstructured":"Samson M, Singh SS, Rama R, Sridevi V, Rajkumar T (2011) XPD Lys751Gln increases the risk of breast cancer. Oncol Lett 2(1):155\u2013159. https:\/\/doi.org\/10.3892\/ol.2010.220","journal-title":"Oncol Lett"},{"issue":"1","key":"9707_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3892\/or_00000854","volume":"24","author":"W Gao","year":"2010","unstructured":"Gao W, Romkes M, Zhong S, Nukui T, Persad RA, Smith PJ et al (2010) Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncol Rep 24(1):257\u2013262. https:\/\/doi.org\/10.3892\/or_00000854","journal-title":"Oncol Rep"},{"issue":"11","key":"9707_CR29","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.7314\/apjcp.2012.13.11.5721","volume":"13","author":"Y Gan","year":"2012","unstructured":"Gan Y, Li XR, Chen DJ, Wu JH (2012) Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population. Asian Pac J Cancer Prev 13(11):5721\u20135724. https:\/\/doi.org\/10.7314\/apjcp.2012.13.11.5721","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1\u20132","key":"9707_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11010-011-1152-3","volume":"362","author":"RC Sobti","year":"2012","unstructured":"Sobti RC, Berhane N, Melese S, Mahdi SA, Gupta L, Thakur H et al (2012) Impact of XPD gene polymorphism on risk of prostate cancer on north Indian population. Mol Cell Biochem 362(1\u20132):263\u2013268. https:\/\/doi.org\/10.1007\/s11010-011-1152-3","journal-title":"Mol Cell Biochem"},{"issue":"4c","key":"9707_CR31","first-page":"2893","volume":"27","author":"DT Bau","year":"2007","unstructured":"Bau DT, Wu HC, Chiu CF, Lin CC, Hsu CM, Wang CL et al (2007) Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res 27(4c):2893\u20132896","journal-title":"Anticancer Res"},{"issue":"6","key":"9707_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.urolonc.2009.08.013","volume":"29","author":"VS Dhillon","year":"2011","unstructured":"Dhillon VS, Yeoh E, Fenech M (2011) DNA repair gene polymorphisms and prostate cancer risk in South Australia\u2013results of a pilot study. Urol Oncol 29(6):641\u2013646. https:\/\/doi.org\/10.1016\/j.urolonc.2009.08.013","journal-title":"Urol Oncol"},{"issue":"1","key":"9707_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10549-004-1004-x","volume":"89","author":"P Chacko","year":"2005","unstructured":"Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR (2005) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 89(1):15\u201321. https:\/\/doi.org\/10.1007\/s10549-004-1004-x","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9707_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1756-9966-28-104","volume":"28","author":"AK Mitra","year":"2009","unstructured":"Mitra AK, Singh N, Garg VK, Chaturvedi R, Sharma M, Rath SK (2009) Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to squamous cell carcinomas of the Head and Neck (SCCHN) and breast cancer in the north Indian population. J Exp Clin Cancer Res 28(1):104. https:\/\/doi.org\/10.1186\/1756-9966-28-104","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"9707_CR35","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.31557\/apjcp.2021.22.12.3809","volume":"22","author":"T Nairuz","year":"2021","unstructured":"Nairuz T, Bushra YU, Kabir Y (2021) Effect of XPD and TP53 gene polymorphisms on the risk of platinum-based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer patients. Asian Pac J Cancer Prev 22(12):3809\u20133815. https:\/\/doi.org\/10.31557\/apjcp.2021.22.12.3809","journal-title":"Asian Pac J Cancer Prev"},{"key":"9707_CR36","doi-asserted-by":"publisher","unstructured":"Crocetto F, Russo G, Di Zazzo E, Pisapia P, Mirto BF, Palmieri A et al (2022) Liquid biopsy in prostate Cancer Management-Current challenges and Future perspectives. Cancers (Basel) 14(13). https:\/\/doi.org\/10.3390\/cancers14133272","DOI":"10.3390\/cancers14133272"},{"key":"9707_CR37","doi-asserted-by":"publisher","unstructured":"Saxby H, Mikropoulos C, Boussios S (2020) An update on the prognostic and predictive serum biomarkers in metastatic prostate Cancer. Diagnostics (Basel) 10(8). https:\/\/doi.org\/10.3390\/diagnostics10080549","DOI":"10.3390\/diagnostics10080549"},{"issue":"1","key":"9707_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40291-015-0169-9","volume":"20","author":"S Salvi","year":"2016","unstructured":"Salvi S, Conteduca V, Gurioli G, Calistri D, Casadio V, De Giorgi U (2016) Impact of candidate genetic polymorphisms in prostate Cancer: an overview. Mol Diagn Ther 20(1):1\u201312. https:\/\/doi.org\/10.1007\/s40291-015-0169-9","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"9707_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.26444\/aaem\/136362","volume":"28","author":"HR Ceja Galvez","year":"2021","unstructured":"Ceja Galvez HR, Salazar Flores J, Torres Sanchez ED, Rojas Bravo D, Reyna Villela MZ, Reyes Uribe E (2021) Genetic profile for the detection of susceptibility to poisoning by exposure to pesticides. Ann Agric Environ Med 28(2):208\u2013213. https:\/\/doi.org\/10.26444\/aaem\/136362","journal-title":"Ann Agric Environ Med"},{"issue":"2","key":"9707_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1006\/dbio.1999.9232","volume":"208","author":"RS Tebbs","year":"1999","unstructured":"Tebbs RS, Flannery ML, Meneses JJ, Hartmann A, Tucker JD, Thompson LH et al (1999) Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev Biol 208(2):513\u2013529. https:\/\/doi.org\/10.1006\/dbio.1999.9232","journal-title":"Dev Biol"},{"issue":"1","key":"9707_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0304-3835(00)00532-2","volume":"159","author":"SZ Abdel-Rahman","year":"2000","unstructured":"Abdel-Rahman SZ, El-Zein RA (2000) The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 159(1):63\u201371. https:\/\/doi.org\/10.1016\/s0304-3835(00)00532-2","journal-title":"Cancer Lett"},{"issue":"8","key":"9707_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/s1568-7864(03)00085-5","volume":"2","author":"Y Wang","year":"2003","unstructured":"Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X (2003) From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2(8):901\u2013908. https:\/\/doi.org\/10.1016\/s1568-7864(03)00085-5","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"9707_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/2491","volume":"20","author":"F Coin","year":"1998","unstructured":"Coin F, Marinoni JC, Rodolfo C, Fribourg S, Pedrini AM, Egly JM (1998) Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 20(2):184\u2013188. https:\/\/doi.org\/10.1038\/2491","journal-title":"Nat Genet"},{"issue":"5","key":"9707_CR44","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/emboj\/18.5.1357","volume":"18","author":"F Coin","year":"1999","unstructured":"Coin F, Bergmann E, Tremeau-Bravard A, Egly JM (1999) Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. Embo j 18(5):1357\u20131366. https:\/\/doi.org\/10.1093\/emboj\/18.5.1357","journal-title":"Embo j"},{"issue":"10","key":"9707_CR45","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.dnarep.2005.07.001","volume":"4","author":"SG Clarkson","year":"2005","unstructured":"Clarkson SG, Wood RD (2005) Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 4(10):1068\u20131074. https:\/\/doi.org\/10.1016\/j.dnarep.2005.07.001","journal-title":"DNA Repair (Amst)"},{"issue":"5","key":"9707_CR46","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1042\/bst20180519","volume":"46","author":"JL Barnes","year":"2018","unstructured":"Barnes JL, Zubair M, John K, Poirier MC, Martin FL (2018) Carcinogens and DNA damage. Biochem Soc Trans 46(5):1213\u20131224. https:\/\/doi.org\/10.1042\/bst20180519","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"9707_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/10408449609017928","volume":"26","author":"J Nair","year":"1996","unstructured":"Nair J, Ohshima H, Nair UJ, Bartsch H (1996) Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol 26(2):149\u2013161. https:\/\/doi.org\/10.3109\/10408449609017928","journal-title":"Crit Rev Toxicol"},{"issue":"6","key":"9707_CR48","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/1055-9965.Epi-06-0736","volume":"16","author":"NL Nock","year":"2007","unstructured":"Nock NL, Tang D, Rundle A, Neslund-Dudas C, Savera AT, Bock CH et al (2007) Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol Biomarkers Prev 16(6):1236\u20131245. https:\/\/doi.org\/10.1158\/1055-9965.Epi-06-0736","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9707_CR49","doi-asserted-by":"publisher","first-page":"e937100","DOI":"10.12659\/msm.937100","volume":"28","author":"X Gu","year":"2022","unstructured":"Gu X, Wu J, Liu X, Hong Y, Wu Y, Tian Y (2022) Role of serum creatinine levels in prognostic risk stratification of prostate Cancer patients. Med Sci Monit 28:e937100. https:\/\/doi.org\/10.12659\/msm.937100","journal-title":"Med Sci Monit"},{"issue":"3","key":"9707_CR50","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.3816\/CGC.2009.n.029","volume":"7","author":"V Launay-Vacher","year":"2009","unstructured":"Launay-Vacher V, Ayllon J, Janus N, Spano JP, Ray-Coquard I, Gligorov J et al (2009) Drug management of prostate cancer: prevalence and consequences of renal insufficiency. Clin Genitourin Cancer 7(3):E83\u2013E89. https:\/\/doi.org\/10.3816\/CGC.2009.n.029","journal-title":"Clin Genitourin Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09707-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:00:55Z","timestamp":1738710055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09707-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9707"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09707-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4236748\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by The Ethical Review Committees of the Department of Biochemistry and Molecular Biology, University of Dhaka, Bangladesh.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and ethics approval"}},{"value":"Informed consent was obtained from all participants before the sample and data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of their clinical data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no conflicting interests. All authors declare they have no financial interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"893"}}